P/E at 63.5 vs Industry's 61.7: What the Data Shows for Apollo Hospitals Enterprise Ltd.

2 hours ago
share
Share Via
A price-to-earnings ratio of 63.52 against an industry average of 61.67 indicates a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMojo, the company’s rating was reassessed on 11 May 2026. The stock’s one-year return of 15.48% comfortably outpaces the Sensex’s decline of 7.94%, yet the recent three-month performance shows a more nuanced picture with a 6.19% gain compared to the Sensex’s sharper 9.58% fall. The data reveals a complex interplay between valuation, performance, and technical indicators.

Valuation Picture: Premium Reflecting Market Confidence

The current P/E of 63.52 for Apollo Hospitals Enterprise Ltd. stands slightly above the hospital industry average of 61.67. This premium, though not extreme, suggests that investors are willing to pay more for the stock relative to its peers, potentially reflecting expectations of superior earnings growth or operational resilience. However, the premium is modest enough to warrant a closer look at whether this valuation is justified by the company’s recent performance and technical positioning — previously rated Hold, what is Apollo Hospitals’ current rating? The valuation premium also aligns with the company’s status as a large-cap leader in the hospital sector, with a market capitalisation of approximately ₹1,15,100 crores.

Performance Across Timeframes: Strong Long-Term Gains Amid Short-Term Fluctuations

Examining the stock’s returns reveals a compelling long-term outperformance. Over the past three years, Apollo Hospitals Enterprise Ltd. has delivered a remarkable 73.72% gain, significantly ahead of the Sensex’s 20.44%. The five-year return is even more striking at 150.43%, compared to the Sensex’s 53.43%, while the ten-year performance stands at an impressive 504.61% versus the Sensex’s 193.09%. These figures underscore the company’s sustained growth trajectory and market leadership.

In contrast, the short-term performance shows a more mixed picture. The stock has gained 6.19% over the last three months, outperforming the Sensex’s 9.58% decline, and has risen 6.52% in the past month against the Sensex’s 2.78% fall. Year-to-date, the stock is up 13.67%, while the Sensex has dropped 12.34%. However, the stock has experienced a minor pullback in the last three days, losing 1% cumulatively, and closed down 0.18% on the most recent trading day, slightly underperforming the Sensex’s 0.20% gain. This short-term volatility may reflect profit-taking or sector-specific factors — is this a temporary correction or a sign of shifting momentum?

Moving Average Configuration: Bullish Technical Setup

From a technical standpoint, Apollo Hospitals Enterprise Ltd. is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This configuration typically signals a strong upward trend and suggests that the recent price action is supported by positive momentum across both short and long-term horizons. The stock is also trading just 1.61% below its 52-week high of ₹8,143.25, indicating proximity to its peak levels over the past year.

Despite the recent three-day consecutive decline, the overall technical picture remains constructive. The fact that the stock remains above all major moving averages implies that the recent dip could be a minor consolidation within a broader uptrend — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Fresh entry alert! This Small Cap from Electronics & Appliances sector is already turning heads in our Top 1% club. Get ahead of the market now!

  • - New Top 1% entry
  • - Market attention building
  • - Early positioning opportunity

Get Ahead - View Details →

Sector Context: Hospital Industry Shows Mixed Results

The hospital sector, within which Apollo Hospitals Enterprise Ltd. operates, has exhibited a varied performance landscape. While some companies have reported positive earnings growth and operational improvements, others have faced challenges from rising costs and regulatory pressures. The sector’s average P/E of 61.67 reflects a generally elevated valuation environment, consistent with the healthcare industry's growth prospects and defensive qualities.

Within this context, Apollo Hospitals maintains a valuation premium, supported by its market leadership and consistent earnings growth. The stock’s recent performance relative to the sector and Sensex highlights its resilience amid sector headwinds — should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Context: Previously Rated Hold, Now Reassessed

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from Hold, reflecting a reassessment of its fundamentals, valuation, and technicals. The previous Mojo Score was 75.0, indicating a solid standing within the large-cap hospital sector. This reassessment takes into account the company’s premium valuation, strong long-term performance, and bullish technical setup, balanced against recent short-term volatility and sector dynamics.

The updated rating invites investors to reanalyse the stock’s position within their portfolios — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Want to dive deeper on Apollo Hospitals Enterprise Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

Conclusion: Data Reflects a Balanced Yet Positive Outlook

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight valuation premium relative to its sector, supported by strong long-term returns and a robust technical setup. While short-term price fluctuations and a minor recent decline introduce some caution, the stock’s position above all major moving averages and proximity to its 52-week high suggest underlying strength.

Investors are encouraged to consider how this valuation-performance tension fits within their investment horizon and risk appetite — should investors in Apollo Hospitals hold, buy more, or reconsider?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News